Form 4 · Filed Jul 10, 2026, 08:15 PM UTC
IMVT/Immunovant, Inc.
Gloria Melanie — Chief Operating Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 8, 2026 | S | sell | 1,930 | $40 | $76,293 | 222,463 |
| Jul 8, 2026 | S | sell | 106 | $40 | $4,239 | 222,357 |
Source: SEC EDGAR raw filing ↗ · Accession 0001764013-26-000083